{"id":"https://openalex.org/W2890134331","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.4519","title":"Infusional gemcitabine + docetaxel/melphalan/carboplatin (GemDMC) \u00b1 bevacizumab (BEV) as an effective high-dose chemotherapy (HDC) regimen for refractory of poor-risk relapsed germ-cell tumors (GCT).","display_name":"Infusional gemcitabine + docetaxel/melphalan/carboplatin (GemDMC) \u00b1 bevacizumab (BEV) as an effective high-dose chemotherapy (HDC) regimen for refractory of poor-risk relapsed germ-cell tumors (GCT).","publication_year":2017,"publication_date":"2017-05-20","ids":{"openalex":"https://openalex.org/W2890134331","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.4519","mag":"2890134331"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2017.35.15_suppl.4519","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.4519","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2017.35.15_suppl.4519","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029237145","display_name":"Yago L. Nieto","orcid":"https://orcid.org/0000-0001-6034-8939","observed_orcids":["https://orcid.org/0000-0001-6034-8939"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yago Nieto","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009388082","display_name":"Shi\u2010Ming Tu","orcid":"https://orcid.org/0000-0003-0015-2111","observed_orcids":["https://orcid.org/0000-0003-0015-2111"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shi-Ming Tu","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008861348","display_name":"Matthew T. Campbell","orcid":"https://orcid.org/0000-0003-1915-4491","observed_orcids":["https://orcid.org/0000-0003-1915-4491"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew T. Campbell","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109591994","display_name":"Roland Bassett","orcid":"https://orcid.org/0000-0002-4534-2042","observed_orcids":["https://orcid.org/0000-0002-4534-2042"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roland Bassett","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058115259","display_name":"Nizar M. Tannir","orcid":"https://orcid.org/0000-0001-5559-8060","observed_orcids":["https://orcid.org/0000-0001-5559-8060"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nizar M. Tannir","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051786644","display_name":"John Francis Ward","orcid":"https://orcid.org/0000-0001-6027-8774","observed_orcids":["https://orcid.org/0000-0001-6027-8774"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Francis Ward","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112255361","display_name":"Wayne Lewis Hofstetter","orcid":"https://orcid.org/0000-0002-4865-2783","observed_orcids":["https://orcid.org/0000-0002-4865-2783"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wayne Lewis Hofstetter","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109241889","display_name":"Roy B. Jones","orcid":"https://orcid.org/0009-0007-7599-7668","observed_orcids":["https://orcid.org/0009-0007-7599-7668"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roy B. Jones","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004417292","display_name":"B\u00f6rje S. Andersson","orcid":"https://orcid.org/0000-0003-4761-0220","observed_orcids":["https://orcid.org/0000-0003-4761-0220"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Borje Andersson","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055885925","display_name":"Alison M. Gulbis","orcid":"https://orcid.org/0000-0003-1921-9152","observed_orcids":["https://orcid.org/0000-0003-1921-9152"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alison M Gulbis","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039986529","display_name":"Celina Ledesma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Celina Ledesma","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023203245","display_name":"Melissa Timmons","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa Timmons","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017847251","display_name":"Michelle Trapp","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle Trapp","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048913229","display_name":"Richard E. Champlin","orcid":"https://orcid.org/0000-0002-4314-5037","observed_orcids":["https://orcid.org/0000-0002-4314-5037"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard E. Champlin","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082402405","display_name":"Lance C. Pagliaro","orcid":"https://orcid.org/0000-0002-4209-3394","observed_orcids":["https://orcid.org/0000-0002-4209-3394"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lance C. Pagliaro","raw_affiliation_strings":["Mayo Clinic, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"35","issue":"15_suppl","first_page":"4519","last_page":"4519"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11069","display_name":"Testicular diseases and treatments","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11069","display_name":"Testicular diseases and treatments","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/germ-cell-tumors","display_name":"germ cell tumors","score":0.878000020980835},{"id":"https://openalex.org/keywords/relapsed-germ-cell-tumors","display_name":"relapsed germ cell tumors","score":0.9539999961853027},{"id":"https://openalex.org/keywords/refractory-germ-cell-tumors","display_name":"refractory germ cell tumors","score":0.9440000057220459},{"id":"https://openalex.org/keywords/high-dose-chemotherapy","display_name":"high-dose chemotherapy","score":0.9739999771118164},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9470000267028809},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.996999979019165},{"id":"https://openalex.org/keywords/melphalan","display_name":"melphalan","score":0.9779999852180481},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":1.0},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9940000176429749},{"id":"https://openalex.org/keywords/ifosfamide","display_name":"ifosfamide","score":0.8159999847412109},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":0.9900000095367432},{"id":"https://openalex.org/keywords/dna-repair-inhibition","display_name":"DNA repair inhibition","score":0.796999990940094},{"id":"https://openalex.org/keywords/tandem-high-dose-chemotherapy","display_name":"tandem high-dose chemotherapy","score":0.703000009059906},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6169999837875366},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7329999804496765}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9015624523162842},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.6287874579429626},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6207713484764099},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5740748643875122},{"id":"https://openalex.org/C2778684742","wikidata":"https://www.wikidata.org/wiki/Q2298283","display_name":"Melphalan","level":3,"score":0.5420253276824951},{"id":"https://openalex.org/C2777506904","wikidata":"https://www.wikidata.org/wiki/Q418560","display_name":"Ifosfamide","level":4,"score":0.5213071703910828},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5087073445320129},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.5082845091819763},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.5067828297615051},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.46284931898117065},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.44419533014297485},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.4353387951850891},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.4344111680984497},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.4258386194705963},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.4206463098526001},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.39561545848846436},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.11470171809196472},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2017.35.15_suppl.4519","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.4519","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2017.35.15_suppl.4519","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2149678989","https://openalex.org/W2586222516","https://openalex.org/W4413572217","https://openalex.org/W2586483573","https://openalex.org/W2333426429","https://openalex.org/W2565035958","https://openalex.org/W2479105106","https://openalex.org/W7141465692","https://openalex.org/W2529393455","https://openalex.org/W2341246941"],"abstract_inverted_index":{"4519":[0],"Background:":[1],"Tandem":[2],"HDC":[3,30,44,69,224],"with":[4,43,159,182,225],"carbo/etoposide":[5],"(CE)":[6],"is":[7],"curative":[8],"for":[9],"a":[10,28,100],"portion":[11],"of":[12,18,32,53,85,241],"relapsed":[13,22],"GCT":[14,54],"pts.":[15],"However,":[16],"outcomes":[17,229],"refractory":[19,136,234],"or":[20],"high-risk":[21],"pts":[23,117,158,167],"remain":[24],"poor.":[25],"We":[26,40,113],"tested":[27],"new":[29],"regimen":[31],"GemDMC,":[33],"based":[34],"on":[35],"DNA":[36],"damage":[37],"repair":[38],"inhibition.":[39],"combined":[41],"BEV":[42,71,242],"given":[45],"their":[46],"potential":[47],"synergy":[48],"and":[49,65,78,123,133,141,171,206,210,220,233],"the":[50,90,237],"high":[51],"vascularity":[52],"metastases.":[55],"Methods:":[56],"Eligibility:":[57],"Intermediate":[58],"(int)/high-risk":[59],"(Beyer":[60],"Model),":[61],"creatinine":[62],"\u22641.8":[63],"mg/dL":[64],"adequate":[66],"organ":[67],"function.":[68],"included":[70],"(5":[72],"mg/kg)":[73],"preceding":[74],"GemDMC":[75],"(HDC":[76,81],"#1)":[77],"ifosfamide/CE":[79],"(ICE)":[80],"#2).":[82],"Following":[83],"accrual":[84],"42":[86],"pts,":[87],"we":[88],"amended":[89],"trial":[91,95,250],"omitting":[92],"BEV.":[93],"The":[94,199],"was":[96],"powered":[97],"to":[98],"distinguish":[99],"target":[101],"50%":[102],"2-yr":[103,200,215],"RFS":[104,201],"from":[105],"an":[106],"expected":[107],"25%":[108],"in":[109,118,146,150,156,169,173,187,203,230],"this":[110],"population.":[111],"Results:":[112],"enrolled":[114],"69":[115],"male":[116],"cohorts":[119,204],"1":[120,149,205],"(BEV,":[121],"N=42)":[122],"2":[124,189,207],"(no":[125],"BEV,":[126],"N=27)":[127],"(Table).":[128],"Pts":[129],"were":[130,168],"heavily":[131,231],"pretreated":[132,232],"most":[134],"had":[135,178],"tumors.":[137],"Main":[138],"AE:":[139],"mucositis":[140],"renal":[142],"(4":[143],"HDC-related":[144],"deaths":[145],"cohort":[147,151],"1,":[148],"2).":[152],"Tumor":[153],"markers":[154],"normalized":[155],"90%":[157],"active":[160],"tumors":[161],"at":[162],"HDC.":[163],"After":[164],"HDC,":[165],"19":[166],"CR":[170],"28":[172],"PRm-":[174],"(of":[175],"these,":[176],"22":[177],"residual":[179],"lesions":[180],"resected":[181],"no":[183],"viable":[184],"tumor":[185,247],"found":[186],"20/22,":[188],"xRT,":[190],"4":[191],"monitored).":[192],"Median":[193],"f/u":[194],"=":[195,208,218],"39":[196],"(2-105)":[197],"mo.":[198],"rates":[202,217],"52%":[209],"78%,":[211],"respectively.":[212],"Their":[213],"respective":[214],"OS":[216],"55%":[219],"81%.":[221],"Conclusions:":[222],"Sequential":[223],"GemDMC\u2013ICE":[226],"shows":[227],"encouraging":[228],"GCT,":[235],"exceeding":[236],"anticipated":[238],"results.":[239],"Addition":[240],"increases":[243],"toxicity":[244],"but":[245],"not":[246],"control.":[248],"Clinical":[249],"information:":[251],"NCT00936936.":[252],"[Table:":[253],"see":[254],"text]":[255]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2018-09-27T00:00:00"}